Earnings Review · 28 October 2026
The print
Results are in but not yet verified against a primary source in our ledger; this review updates the moment the audited figures land. What does not change is our read below.
Did the flow confirm the move?
Underlying money flow reads as distribution (21-day Chaikin Money Flow -0.37, five-day price change -3.6%, as of 2026-10-23, desk flow model).
Give the business its due
The business itself is genuinely strong: revenue growing about 28%, net margins near 8%, a moderate competitive moat, backed by a 23% return on equity.
Levels that matter
At $53.60 the shares sit 17% below the 52-week high of $64.35 and 19% above the low of $45.01 (44% of the way up the range).
The valuation lens
The shares trade close to our fair-value estimate (-2% margin of safety): fairly priced, little cushion for a miss. Fair value lands near $53 against a $53.60 share price, a margin of safety of about -2%. The trailing multiple sits around 25 times earnings, which only makes sense if the growth holds.
The ethical lens, our differentiator
Fails the principled screen, Business activity. A strong business is not the same as a suitable one; for a values-conscious book this is a do-not-chase regardless of the print.
The compliant alternative
There is no direct compliant equivalent in the same industry on our screen, the honest answer is to screen a step wider rather than reach for a false substitute.
The verdict for a values-conscious investor
A beat-and-raise does not change the screen. This is a great company you can admire without owning, protection first. One quarter, strong or soft, does not decide whether a holding is suitable.
This is analysis, not financial advice. Always manage your risk.
